InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: rosemountbomber post# 407947

Monday, 05/01/2023 9:38:41 AM

Monday, May 01, 2023 9:38:41 AM

Post# of 425931
A combo drug from Pfizer and Astellos proves effective...

QUOTE..." Pfizer, Astellas Xtandi combo cuts risk of death by 58% in prostate cancer patients

Pfizer (NYSE:PFE) and Astellas Pharma (OTCPK:ALPMF) (OTCPK:ALPMY) said Xtandi (enzalutamide) plus leuprolide significantly reduced the risk of metastasis or death by 58%, compared to the leuprolide placebo combo in patients with a type of prostate cancer in a phase 3 trial."

How about a combo drug with Lipitor plus EPA significantly reducing CVD compared to Lipitor alone!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News